Withings’ Move ECG smartwatch is now available across Europe. Billed as “the world’s first analog watch to record an ECG on-demand,” Move ECG packs state-of-the-art medical technology into a stylish, everyday watch.
The new device is specifically engineered to detect and monitor AFib, a heart irregularity that’s responsible for one-third of all strokes in the developed world. While as many as 1 in 4 adults living in Europe and the US develop AFib in their lifetime, the condition is easy to miss and often goes undiagnosed.
Move ECG uses three discrete, strategically placed electrodes to monitor an individual’s pulse. When experiencing heart palpitation, or other symptoms, a monitor button on the side is pressed, prompting the device to start recording. Roughly 30 seconds later, the watch sends the results to the Health Mate smartphone app (iOS and Andriod) where wearers can analyze and share the information with their doctors.
In addition to monitoring AFib, Move ECG also features market-leading fitness and sleep tracking capabilities. When it comes to working out, the watch has the ability “to track calories burned, pace, distance, workout routes, and elevation.” Furthermore, the device automatically detects when you’ve started a particular exercise and sends the data to the app for tracking.
As for sleep monitoring, Move ECG offers “analysis of sleep patterns, including the length, depth, and quality of sleep.” It also has a feature called “Smart Wake-up that will wake users with vibration alarms at the most optimal times during their sleep cycle.”
Move ECG is currently available via the company’s official website and Amazon for €129.95/£129.95. Withings says a US version will be available sometime after October.